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Background: The CORONIS Trial was a 2×2×2×2×2 non-regular, fractional, factorial trial of five pairs of alternative
caesarean section surgical techniques on a range of short-term outcomes, the primary outcome being a composite
of maternal death or infectious morbidity. The consequences of different surgical techniques on longer term
outcomes have not been well assessed in previous studies. Such outcomes include those related to subsequent
pregnancy: mode of delivery; abnormal placentation (e.g. accreta); postpartum hysterectomy, as well as longer term
pelvic problems: pain, urinary problems, infertility. The Coronis Follow-up Study aims to measure and compare the
incidence of these outcomes between the randomised groups at around three years after women participated in
the CORONIS Trial.
Methods/Design: This study will assess the following null hypotheses: In women who underwent delivery by
caesarean section, no differences will be detected with respect to a range of long-term outcomes when comparing
the following five pairs of alternative surgical techniques evaluated in the CORONIS Trial:
1. Blunt versus sharp abdominal entry
2. Exteriorisation of the uterus for repair versus intra-abdominal repair
3. Single versus double layer closure of the uterus
4. Closure versus non-closure of the peritoneum (pelvic and parietal)
5. Chromic catgut versus Polyglactin-910 for uterine repair
The outcomes will include (1) women’s health: pelvic pain; dysmenorrhoea; deep dyspareunia; urinary symptoms;
laparoscopy; hysterectomy; tubal/ovarian surgery; abdominal hernias; bowel obstruction; infertility; death. (2) Outcomes
of subsequent pregnancies: inter-pregnancy interval; pregnancy outcome; gestation at delivery; mode of delivery;
pregnancy complications; surgery during or following delivery.
Discussion: The results of this follow-up study will have importance for all pregnant women and for health professionals
who provide care for pregnant women. Although the results will have been collected in seven countries with limited
health care resources (Argentina, Chile, Ghana, India, Kenya, Pakistan, Sudan) any differences in outcomes associated with
different surgical techniques are likely to be generalisable throughout the world.
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Caesarean section is one of the most commonly per-
formed operations worldwide and accounts for up to
60% of deliveries in some countries, with a rate of ap-
proximately 24.6% in the UK in 2008/2009 [1]. The op-
eration is not performed in a standardised way, and
there are variations in the surgical techniques used [2].
Caesarean section carries a risk of short-term post-
operative morbidity, for example, fever, pain and post-
partum haemorrhage. Also of major importance are the
long-term clinical and obstetric problems such as
chronic pain, infertility, bowel obstruction, abnormal
placentation and its consequences, and uterine rupture.
The effects of caesarean techniques on these long-term
outcomes have not been well assessed in randomised
controlled trials to date [3].
The MRC funded CORONIS Trial is a 2×2×2×2×2
fractional, factorial trial of different surgical techniques
at caesarean section. The trial is comparing (1) blunt
versus sharp abdominal entry; (2) exteriorisation of the
uterus for repair versus intra-abdominal repair; (3) single
versus double layer closure of the uterus; (4) closure ver-
sus non-closure of the peritoneum (pelvic and parietal);
(5) chromic catgut versus Polyglactin-910 for uterine re-
pair, on a range of short-term outcomes, the primary
outcome being a composite of maternal death or mater-
nal infectious morbidity.
Summary of existing evidence
Existing systematic reviews of randomised controlled tri-
als have been unable to draw clear conclusions about
whether any of the techniques being compared in the
CORONIS Trial are to be preferred [4-9]. Optimisation
of surgical techniques may be able to reduce both the
short-term and the long-term morbidity associated with
caesarean section and although differences may be rela-
tively modest, the commonness of the operation means
that even small improvements in outcome may result in
substantial improvements in health for many thousands
of women and considerable cost savings for health
services.
Short-term outcomes are the primary outcomes evalu-
ated in most of the trials assessing alternative techniques
for caesarean section. These are often surrogate out-
comes and are usually only measured up to 6 weeks after
the caesarean section. The most common outcomes
assessed are:
 operative time and length of postoperative stay
 use of extra haemostatic sutures
 defects in the uterine scar or thickness of the
uterine scar
 infection or complications of the wound
 postpartum endometritis decrease in postoperative haematocrit
 use of blood transfusion
 fever or postoperative febrile morbidity
 pain




 admission to neonatal unit
It is clear that the most important differences in terms
of maternal outcomes between different surgical tech-
niques may be apparent in the long-term, including the
functional integrity of the uterine and abdominal scar
during subsequent pregnancies and other long-term
post-operative effects such as chronic pelvic pain, infer-
tility, peritoneal and bowel adhesions and obstruction
[10]. Even in the absence of short-term effects, there
may well be important long-term differences between
the randomised groups (a situation not dissimilar to that
seen in the MRC funded ORACLE Trial where there
were no short-term differences seen [11]. However, in
the 7-year follow-up of the children born to women pre-
senting in preterm labour with intact membranes, there
was an excess of cerebral palsy in the children of
mothers treated with antibiotics compared with those
who received placebo [12]). In CORONIS, there is a real
possibility that long-term effects may go in the opposite
direction to the short-term effects. For example, non-
closure of the peritoneum is quicker than closure and
may therefore result in less infectious morbidity in the
short-term. However, it may also be associated with in-
voluntary infertility because of excessive intraperitoneal
adhesion formation.
Therefore long-term outcomes, even if uncommon,
are more likely to have a higher impact on morbidity
and can occasionally result in life-threatening events or
even death. The long-term outcomes assessed in the few
existing studies are: fertility (infertility) after caesarean
section, chronic pain, dyspareunia, constipation, adhe-
sion formation and uterine rupture [10,13-16]. Some of
these outcomes can only be assessed by measuring mor-
bidity in subsequent pregnancies or at subsequent epi-
sodes of abdominal surgery. Therefore, trials with large
sample sizes are needed to ensure adequate power to
draw conclusions about long-term outcomes between
compared groups.
A systematic review of the literature has shown that to
date there have been only three long-term follow-up
studies of the existing randomised trials of caesarean
section techniques. One investigated the long-term ef-
fects of single versus double layer uterine closure and
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paring closure versus non-closure of the peritoneum in a
subsequent pregnancy [10,13,14]. The sample sizes of
these follow-up studies are small and included only 18%
of the women randomised into the original trials for two
of them [10,13] and 51% for the third [14]. In the only
study that compared single versus double layer uterine
closure, no statistically significant difference was found
on the following outcomes: inter-pregnancy interval, va-
ginal delivery, length of hospital stay, preterm delivery,
amnionitis, postpartum endometritis, placental abrup-
tion, postpartum haemorrhage, blood transfusion or
uterine dehiscence. However, this was only based on a
sample size of 145 women out of the 906 randomised in
the original trial [13]. From the two follow-up studies of
randomised trials comparing closure versus non-closure
of the peritoneum (209 women in total), no differences
were observed in terms of intra-abdominal adhesions
(65 women evaluated out of the 360 originally rando-
mised) [10], abdominal pain, dyspareunia, constipation,
urinary symptoms and infertility (144 women included
out of the 280 originally randomised) [14].
Given the relatively low incidence of uterine rupture
(0.4 to 0.6% for women undergoing a trial of labour ver-
sus 0.2% for those having elective repeat caesarean) and
dehiscence (1.1%) [17], attempts to detect differences in
these outcomes between different surgical techniques
with adequate power is challenging. However, the one
large observational study that has looked at this out-
come is weakened by several potentially interrelated fac-
tors [15]. For example, the caesarean technique used
changed from mainly double layer closure to mainly sin-
gle layer closure during the period studied, and the se-
lection criteria for trial of labour may have changed in
this time too. Thus women who had single layer closure
may have been more likely to have a trial of labour. Well
conducted follow-up studies of randomised trials remain
the best option to evaluate these outcomes reliably.
There are still very important outcomes that have not
been assessed by any randomised trial or observational
study, which have major implications for the health of
women and their babies. These include for example:
mode of delivery of subsequent pregnancy, the risk of
placenta accreta and other abnormal placentation, and
postpartum hysterectomy.
Placenta accreta is strongly linked to placenta praevia,
a condition recognised to increase as the number of pre-
vious caesarean sections rises [18-20]. The presence of
placenta accreta is associated with major pregnancy
complications, including life-threatening maternal haem-
orrhage, uterine rupture, peripartum hysterectomy [21]
and maternal death, as well as complications associated
with surgical removal including damage to bladder, ure-
ters and other organs [22]. We know of no randomisedtrials comparing different techniques for caesarean sec-
tion assessing this important outcome.
There has been one large observational study of peri-
partum hysterectomy relating this to previous caesarean
section. This study [21], carried out in the UK, collected
all cases of peripartum hysterectomy during a 13 month
period. There were 318 confirmed cases of peripartum
hysterectomy in an estimated 779,955 total births, giving
an incidence of 4.1 per 10,000 total births (95% CI 3.6 to
4.5). Three hysterectomies were undertaken electively
for management of malignancy with the remaining 315
undertaken for management of haemorrhage. The most
commonly reported causes of haemorrhage were uterine
atony (53%), morbidly adherent placenta (39%), uterine
rupture (8%) and extension of uterine incision at delivery
(6%). Compared with controls, women who had had a
peripartum hysterectomy had over three times the odds
(odds ratio 3.52, 95% CI 2.35 to 5.26) of having a previ-
ous caesarean section. This odds ratio increased with the
number of previous sections such that women with a
peripartum hysterectomy had over eighteen times the
odds of having two or more previous sections compared
to control women. In this study, two women died, a case
fatality of 0.6% (95% CI 0 to 1.5%).
This study did not collect data about the surgical tech-
niques used at previous caesarean section but it does il-
lustrate the evidence that is beginning to emerge about
the important longer term morbidity associated with
caesarean section.
There are no on-going studies of long-term follow-up
of randomised controlled trials of caesarean section that
any of the investigators are aware of. The UK CAESAR
Trial [23], which was a 2×2×2 factorial trial of (i) single
versus double layer uterine closure, (ii) closure versus
non-closure of the pelvic peritoneum and (iii) liberal ver-
sus restricted use of a sub-sheath drain has finished
recruiting and long-term follow-up of this cohort is
planned. This trial was also conducted by the National
Perinatal Epidemiology Unit (NPEU) and follow-up is
planned for 8–11 years after trial recruitment because
the inter-pregnancy interval is substantially longer in a
UK population than in the settings participating in
CORONIS. A prospective meta-analysis of the trial
follow-up studies (for single versus double layer uterine
closure) is planned.
The CORONIS Trial (https://www.npeu.ox.ac.uk/coronis)
The objectives of the CORONIS Trial are to determine
whether there are any differences in short-term maternal
morbidity when comparing five pairs of alternative surgi-
cal techniques undertaken during the time of caesarean
section. Information was collected at trial entry, immedi-
ately following the operation, at discharge from hospital
and at six weeks after delivery. The CORONIS Trial
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Trial eligibility
Women are eligible for trial entry if they are undergoing
delivery by lower segment caesarean section through a
transverse abdominal incision, irrespective of fever in
labour, gestational age or whether they have a multiple
pregnancy.
Women are not eligible if: (i) there is a clear indication
for a particular surgical technique or material to be used
that prevents any of the allocated interventions being
used; (ii) they have had more than one previous caesar-
ean section; (iii) they have already been recruited into
the trial during a previous pregnancy.
Trial primary outcome
Death or maternal infectious morbidity (one or more of
the following: antibiotic use for maternal febrile morbid-
ity during postnatal hospital stay, antibiotic use for
endometritis, wound infection or peritonitis) or further
operative procedures; or blood transfusion (>1 unit of
whole blood or packed cells).
Trial interventions
There are five pairs of interventions being tested in the
trial; however, each participating hospital only takes part
in three of these five possible comparisons. The non-
allocated comparisons and all other aspects of the cae-
sarean section are performed at the discretion of the
surgeon.
1. Blunt versus sharp abdominal entry
2. Exteriorisation of the uterus for repair versus intra-
abdominal repair
3. Single versus double layer closure of the uterus
4. Closure versus non-closure of the peritoneum
(pelvic and parietal)
5. Chromic catgut versus Polyglactin-910 for uterine
repair
Factorial trials
Factorial trials maximise the efficiency of a trial by in-
cluding more than one trial question into a single trial
population. Instead of having one trial which compares,
for example, single versus double layer closure of the
uterine incision and another trial comparing closure ver-
sus non-closure of the peritoneum, both comparisons
can be combined into one trial using only the number of
women necessary to answer one of these questions in
isolation. In the CORONIS Trial, five comparisons have
been carried out in one trial. Such a design has rarely
been used, but is appropriate for the evaluation of sev-
eral procedures which will be used together in clinicalpractice. In such a trial of different caesarean section
techniques, using five pairs of possible allocated inter-
ventions (1 versus “not 1”, 2 versus “not 2”, 3 vs. versus
“not 3”, 4 versus “not 4”, 5 versus “not 5”), participants
can receive one of 32 possible alternatives.
In the analysis of a factorial trial the same process is
used for a 2×2×2×2×2 factorial design as for a 2×2 fac-
torial design. All those allocated 1 are compared with all
those allocated “not 1” regardless of what other inter-
ventions were allocated, provided that there is no
interaction.Fractional factorial trials
In a standard 2×2×2×2×2 factorial design, all partici-
pants would receive one of 32 possible alternatives, and
each of these alternatives would include five interven-
tions. The CORONIS Trial is a fractional factorial de-
sign, and, therefore, each participant was allocated only
three out of the five possible interventions. Such an in-
complete factorial design was considered appropriate be-
cause it allows five surgical techniques to be tested in
the same trial, but restricts the number of techniques
being tested per centre and per surgeon to three. Hence,
each centre was required to implement training for three
(not five) surgical techniques and each surgeon was re-
quired to remember the three (not five) allocated tech-
niques for every randomised woman.
There were two main implications of this incomplete
factorial design. First, in the trial design, we ensured that
a similar number of women were included in each of the
five comparisons. Second, in the analysis, we will not be
able to test for interactions between more than three
interventions.
CORONIS recruited in excess of 15,000 women in
Argentina, Chile, Ghana, India, Kenya, Pakistan and
Sudan. This represents a unique cohort of women to fol-
low up to assess and compare their long-term health
outcomes between the different randomised compo-
nents. In order to ensure a high rate of follow-up while
maximising the number of women who will have had a
subsequent pregnancy, we have chosen to follow up this
cohort at least three years after their participation in
CORONIS. Any longer and we risk losing women to
follow-up, any shorter and we decrease the number of
women who will have had a subsequent pregnancy and
therefore limit our power to address important potential
differences in outcome.Methods/Design
The CORONIS Follow-up study
Objective
The objective of the CORONIS Follow-up Study is to
measure and compare the incidence of outcomes at
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women who participated in the CORONIS Trial.
Hypothesis
This study will assess the following null hypotheses: In
women who underwent delivery by caesarean section, no
differences will be detected with respect to a range of
long-term outcomes when comparing the following five
pairs of alternative surgical techniques:
1. Blunt versus sharp abdominal entry
2. Exteriorisation of the uterus for repair versus intra-
abdominal repair
3. Single versus double layer closure of the uterus
4. Closure versus non-closure of the peritoneum
(pelvic and parietal)
5. Chromic catgut versus Polyglactin-910 for uterine
repair
Tracing women
All women participating in the CORONIS Trial have
been informed that we hope to be able to interview
them at least three years after they were included in
CORONIS to ask them about their long-term health.
The trial entry information leaflet contains the follow-
ing paragraph:
“We are also keen to find out whether the different
methods used make any difference to your long-term
health. We would like to contact you again after the
study has finished. We will ask you how you are and
whether you have had any more babies.”
In addition, at the ‘six week’ follow-up appointment,
women are provided with the following letter:
“Thank you for taking part in CORONIS and for
letting us know about your health since your
caesarean section.”
We hope to see all women who take part in the study
once more. This will be three years after the caesarean
section. At this visit we will also ask about your health
since your caesarean section. Because a lot can
happen in three years, we will keep in touch with you
every 6 months or so to make sure we have your
correct phone number and address.
If you have any more pregnancies or have any surgery
it would be very helpful if you, or your doctor, could
write these down on the CORONIS Medical Card.
This will make it easier for you to remember
everything that has happened since your caesarean
section.If you move house or change your phone number,
please fill in the Change of Address card and send it
back to the Study Office, or phone us. The phone
number and address are: [details]
“If you do not want to take part in the study any
more, you can let us know by phoning or writing to the
Study Office. Thank you for your help with this study.”
To facilitate long-term follow-up women have been
provided with a medical card and a document bag for
storing their medical information. This bag has the
CORONIS Trial logo printed on the outside and con-
tains information about letting the local Regional Trial
Office know if the woman moves house or changes other
contact details.
The process of maintaining contact with women who
participated in CORONIS between their six week
follow-up and the three year follow-up is coordinated by
each Regional Trial Office to reflect differences in the
circumstances between the very different settings for this
trial.
Outcomes
The list below represents the full range of outcomes
relevant to the five intervention pairs being evaluated.
Women’s health and mortality
1. Following the CORONIS birth and before any




iv. urinary symptoms of poor stream and/or
frequency which did not respond to antibiotics
2. Diagnostic laparoscopy or diagnostic laparotomy
(not related to pregnancy)
3. Hysterectomy or tubal/ovarian surgery (not related
to pregnancy)
4. Bladder or bowel damage in those women who have
had surgery, excluding diagnostic laparoscopy and
diagnostic laparotomy (not related to pregnancy).





7. Number of women with no subsequent pregnancy
i. Voluntary infertility
ii. Involuntary infertility
8. Use of fertility treatments
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9. Number of women having any subsequent
pregnancy and for these women, the following
outcomes will be measured:
i. Inter-pregnancy interval from the CORONIS
birth to the end of the subsequent pregnancy
(regardless of loss or birth)
ii. Miscarriage of the pregnancy subsequent to the
CORONIS birth
iii. Ectopic pregnancy
For the birth following the CORONIS birth:
iv. Gestation at delivery (by best estimate) of the first
viable pregnancy (gestational age > 24 or




vii. Mode of delivery:
a. Non-instrumental vaginal
b. Instrumental vaginal
c. Pre-labour caesarean section
d. In labour caesarean section
viii.Other pregnancy complications (one or more of
the following components: uterine rupture,
uterine scar dehiscence, placenta praevia,
morbidly adherent placenta, abruption,
postpartum haemorrhage requiring transfusion
>1 unit of whole blood or packed cells, severe
infection within 6 weeks postpartum,
hysterectomy up to 6 weeks postpartum, manual
removal of placenta)
ix. Bladder or bowel damage at the time of
subsequent caesarean sectionCORONIS children – morbidity and mortality
10. Death or serious morbidity of the child who was
born at the time of CORONIS participation.
Parent report of one or more of the following: child's
blindness, deafness, inability to speak or walk without as-
sistance, or other major morbidity such as the presence of
a stoma. Although no difference in death is expected,
there is likely to be a time difference between ‘sharp’ and
‘blunt’ abdominal entry and this may, in theory, lead to
more neonatal encephalopathy which may lead to a
greater risk of later death.
All outcomes are potentially relevant for each com-
parison pair; however, some outcomes are more likely to
be influenced by some interventions compared with
others. Therefore we have categorised comparisons into
(i) main comparisons of interest, and (ii) secondary com-
parisons of interest (Table 1). This approach has beenpre-specified to take account of multiple testing and to
simplify reporting of the study. Only the main compari-
sons of interest will be reported in the main paper, al-
though the remaining comparisons will be presented in
appendices to ensure transparency and completeness of
the analysis.
Data collection
Most of the information requested will be provided by
the woman at face-to-face interview. Many of the out-
comes being collected are clinical diagnoses which are
made every day by clinicians in these settings. Women
will be asked whether they have pelvic pain and pain on
intercourse. Whether or not they have sought or re-
ceived medical care for their pain will be used as a
marker of severity. For women who are pregnant at the
time of the follow-up, data will be collected once the
pregnancy is over.
For the relatively small number of women who have
one of the outcomes resulting in hospitalisation (includ-
ing subsequent pregnancy complications, such as uterine
rupture or dehiscence, hysterectomy, placenta praevia,
or other morbidity including non-pregnancy related hys-
terectomy and laparoscopy/laparotomy), consent will be
requested from the women to access their hospital
notes, so that additional information relating to the inci-
dent can be collected from the relevant hospital by the
assessment doctors. Although medical records in some
settings in these countries may be poor, this mechanism
is being used to seek confirmation of events. We will not
use these data as the primary source of the outcome
data – these come from the women. In addition any
relevant laboratory reports and histopathology will be
used by the clinicians reporting morbidity to support
their diagnosis. We will collect these data, but we do not
require these for confirmation of the diagnosis. For ex-
ample a post-partum hysterectomy histopathology report
will not be required to support a diagnosis of a morbidly
adherent placenta but will be used as supportive evi-
dence, if it is available.
Analysis
A detailed Statistical Analysis Plan (SAP) will be devel-
oped and agreed by the Study Steering Committee (SSC)
before the analysis is undertaken.
Analysis populations
For the primary analyses, all maternal and child out-
comes will be analysed in the groups into which they
were randomly allocated e.g. comparing the outcome of
all women allocated “blunt abdominal entry” with all
those allocated “sharp abdominal entry”, regardless of
technique received. Maternal and child outcomes will be
Table 1 Comparisons of interest (M denotes main comparisons of interest, s denotes secondary comparisons of interest)
Outcome reference
number
Outcome Bl vs. Sh Ext vs.-A Sl vs. Dble Cl vs. N-Cl Cat vs. P910
Women‘s health and mortality
1 i) Pelvic pain s s s M s
ii) Dysmenorrhoea s s s s s
iii) Deep dyspareunia s s s M s
iv) Urinary symptoms s s s s s
2 Diagnostic laparoscopy or diagnostic laparotomy - not
related to pregnancy
s s s M s
3 Hysterectomy or tubal/ovarian surgery - not related to
pregnancy
s s s M s
4 Bladder or bowel damage – not related to pregnancy s s s M s
5 i) Abdominal hernias M s
ii) Bowel obstruction s s s M s
6 Woman’s death s M s M
Reproductive status
7 i) Women with no subsequent pregnancy – voluntary s s
ii) Women with no subsequent pregnancy – involuntary s M s M s
8 Fertility treatments s M s M s
Subsequent pregnancies
9 Any subsequent pregnancy s s s s s
i) Interpregnancy interval s s s s s
ii) Miscarriage s s s
iii) Ectopic pregnancy M s M s
iv) Gestation s s s
v) Stillbirth s M M
vi) Neonatal death s M M
vii) Mode of delivery s M M
viii) Other pregnancy complications (composite of a-i) s M M
a Uterine rupture s M M
b Uterine scar dehiscence s M M
c Placenta praevia s M M
d Morbidly adherent placenta s M M
e Abruption s M M
f Postpartum haemorrhage requiring transfusion of >1 unit
of whole blood or packed cells
s M M
g Severe infection within 6 weeks postpartum s M M
h Hysterectomy up to 6 weeks postpartum s M M
i Manual removal of placenta s M M
ix) Bladder or bowel damage –at the time of subsequent
Caesarean section
s s s s s
CORONIS children – morbidity and mortality
10 Death or serious morbidity of CORONIS child M
Key: Bl vs. Sh = Blunt versus sharp abdominal entry, Ext vs. I-A = Exteriorisation of the uterus for repair versus intra-abdominal repair, Sl vs. Dble = Single versus
double layer closure of the uterus, Cl vs. N-Cl = Closure versus non-closure of the peritoneum (pelvic and parietal), Cat vs. P910 = Chromic catgut versus
Polyglactin-910 for uterine repair.
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whom data are available.
The outcomes of interest for women who have a sub-
sequent viable pregnancy, such as uterine rupture, will
be analysed using two different denominators i.e. women
who subsequently have at least one pregnancy and all
women randomised. This will take account of the poten-
tial for differences in the pregnancy rate between the
two arms being compared.Descriptive analyses
The flow of participants through each stage of the trial
will be illustrated in a CONSORT flowchart [24,25]. This
will include the numbers (with percentages) of losses to
follow-up over the period of the follow-up study (includ-
ing reasons, where known) by pair of interventions.
Baseline demographic and clinical characteristics will
be described separately for the five intervention pairs in
the main trial publication, for those women for whom
follow-up data are collected. We will compare the char-
acteristics of such women with those for whom no
follow-up assessment was possible using tests of statis-
tical significance, overall and by pair of interventions.Primary comparative analyses
The primary analyses will be performed on each of the
five pairs of surgical techniques. Outcomes will be
summarised by intervention group using appropriate
summary statistics (counts and percentages, means and
standard deviations, or medians and inter-quartile
ranges). Comparisons will be made using relative risks
(RR) for dichotomous/categorical outcomes, mean dif-
ferences for normally distributed continuous outcomes,
or median differences for skewed continuous variables
(unless the data can be transformed to normality). Ana-
lysis of time to event outcomes will employ survival ana-
lysis techniques [26].
Multiplicity of statistical testing will be addressed in
the detailed statistical analysis plan.
With regard to the analysis of child outcomes, mul-
tiple births will be treated as independent events in the
primary analysis, in order that relative risks may be
presented.
Adjusted analyses will be performed on all compari-
sons to investigate the impact of minimsation factors
‘In-labour or not in-labour caesarean section’ and ‘num-
ber of previous caesarean sections (none or one)’. These
will be agreed by the investigators and the Study Steer-
ing Committee and pre-specified in the SAP.
Subgroup analyses will be similarly agreed and pre-
specified in the statistical analysis plan and results will
be presented on forest plots, by intervention pair, wher-
ever appropriate.The robustness of the results will be examined in sen-
sitivity analyses by using multiple imputation techniques
to impute missing 3 year follow-up data, and also
restricting analyses to a pre-specified follow-up window.
Sensitivity of the effect estimates to adjustments for
potential clustering of multiple births will also be
examined.
Interactions will be explored using a structured ap-
proach. Plausible interactions are difficult to identify and
not all can be assessed due to the nature of the trial de-
sign. A strategy for the analysis of interactions for the
main trial has been agreed by the Trial Steering Com-
mittee to prevent the investigators being misled by
spurious interactions, given the multiplicity of possible
explorations. This strategy will be employed for the pri-
mary analysis of the follow-up study i.e. analyses of
interactions will only be performed on the main compar-
isons; and three-way interactions will not be investigated
unless there is strong evidence of a two-way interaction
in the presence of main effects. The results of the ex-
ploration of interactions will be interpreted cautiously
together with other evidence such as biological plausibil-
ity and consistency (e.g. across countries). Plausible in-
teractions for each outcome will be agreed by the
investigators and the Study Steering Committee and
pre-specified in the SAP.
Sample size and power
The original sample size for the main trial was calculated
assuming a 15% primary outcome event rate in the con-
trol group (80% power, 5% two-sided significance level,
ability to detect a relative risk of 0.85, 15% loss to
follow-up) which resulted in a total sample size required
of ~ 15,000 women (~ 9,000 in each intervention pair).
The actual overall event rate observed during the con-
duct of the trial was found to be around 9%. The sample
size was increased to 15,492 (9,296 per intervention pair)
to account for the reduction in the event rate and agreed
by the TSC.
Assuming an overall response rate of at least 80% for
the follow-up [27,28], this will provide us with informa-
tion from ~12,400 women (or ~7,400 for each interven-
tion pair). If we assume approximately 80% of these
women will have had a subsequent pregnancy this will
result in ~5,900 women in each intervention pair. This
number will be sufficient to detect modest but clinically
important differences between any principal comparison
for this population.
The statistical power available, based on a fixed sample
size, for a range of event rates on a selection of out-
comes is high (Table 2). These incidence rate estimates
are based on two follow-up studies of randomised trials,
both of which were from developed countries where the
event rates are likely to be lower than those observed in
Table 2 power to detect a specified difference for a fixed sample size
Outcome examples Event rate in 1st group
e.g. single layer closure
Event rate in 2nd group





For all women (number estimated to be ~7,400)
Involuntary infertility 3% 4.5% 1.5% 92%
Subsequent pregnancy 48% 44% 4% 93%
Dyspareunia 19% 16% 3% 92%
For women who have a subsequent pregnancy (number estimated to be ~5,900)
Uterine rupture or dehiscence 4% 5.9% 1.9% 92%
Preterm birth 10% 7.5% 2.5% 93%
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therefore, are likely to represent a conservative estimate
of the anticipated event rates. One study was following a
trial of closure versus non-closure of the peritoneum
[12] and the other following single versus double layer
closure of the uterine incision13. Both studies were small
(n = 145 and 144 women) and the estimates of some of
the outcomes are therefore imprecise. For example, the
estimate of uterine dehiscence is based on 1 event out of
145 women, giving an incidence of 0.69% with a 95%
confidence interval of 0.12% to 3.8%. The estimate of
dyspareunia is based on 27 events out of 144 women
giving an incidence of 19% with a 95% confidence inter-
val of 13% to 26%.
The power calculations in Table 2 assume equal num-
bers in each comparison and a 2-5% level of statistical
significance.
Discussion
The results of the CORONIS Follow-up Study will have
importance for all pregnant women and for health pro-
fessionals who provide care for pregnant women. Al-
though the results will have been collected in seven
countries with limited health care resources (Argentina,
Chile, Ghana, India, Kenya, Pakistan, Sudan) any differ-
ences in outcomes associated with different surgical
techniques are likely to be generalisable throughout the
world. For example, if non-closure of the peritoneum re-
sults in a greater risk of involuntary infertility this find-
ing would be relevant to any country setting.
Publication and dissemination of results
It is important that the findings of this research are
widely disseminated. The dissemination strategy will in-
clude publication in high impact peer-reviewed journals
and presentations at research conferences around the
world. In addition, direct communication with a number
of policy making organisations will be undertaken. This
will include the UK Departments of Health, the Royal
College of Obstetricians and Gynaecologists (who have
an increasing presence and influence in producing clin-
ical guidelines for developing countries), the WorldHealth Organisation and the Ministries of Health in each
of the participating countries. Consumer organisations
with an interest in improving maternity care will also be
informed of the study results. Encouraging the rapid in-
corporation of the results into relevant Cochrane re-
views, including the Reproductive Health Library will
also assist in dissemination. The Chief Investigator will
co-ordinate dissemination of data from this study. To
safeguard the scientific integrity of the study, all pro-
posals for subsidiary studies linked to the Follow-up
Study should be presented to the Project Management
Group for approval. All publications from subsidiary
studies using data from the original analyses must be
submitted to the Study Steering Committee for review
before publication. Data from the study will not be pre-
sented in public before the main results are published
without the prior consent of the SSC.
The Chief Investigator will co-ordinate dissemination
of data from this study. To safeguard the scientific integ-
rity of the study, all proposals for subsidiary studies
linked to the Follow-up Study should be presented to
the Project Management Group for approval. All publi-
cations from subsidiary studies using data from the ori-
ginal analyses must be submitted to the Study Steering
Committee for review before publication. Data from the
study will not be presented in public before the main re-
sults are published without the prior consent of the SSC.
The success of the study depends on a large number
of clinicians and participants. For this reason chief credit
for the results will not be given to the committees or
central organisers but to all who have collaborated and
participated in the study.
Authorship at the head of the primary follow-up re-
sults paper will take the form ‘The CORONIS Collabora-
tive Group’. This avoids giving undue prominence to any
individual. All contributors to the study will be listed at
the end of the report, with their contribution to the
study identified. This will include all members of the
Study Steering Committee, the Project Management
Group, the International Co-ordinating Centre, the Re-
gional Trial Offices and local investigators at all partici-
pating sites.
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specific aspects of the study may wish to utilise a differ-
ent authorship model, such as “[name], [name] and
[name] on behalf of The CORONIS Collaborative
Group”.
Decisions about authorship of additional papers will
be discussed and agreed by the investigators. Authorship
of these papers should follow standard academic rules.
The criteria for authorship are:
 Substantial contributions to conception and design,
or acquisition of data, or analysis and interpretation
of data.
 Drafting the article or revising it critically for
important intellectual content
 Final approval of the version to be published.
All authors should fulfill all of the criteria for
authorship.
Acquisition of funding, collection of data or general
supervision alone does not of itself justify authorship.
Presentations given about CORONIS should include
an acknowledgement of the contribution of all the inves-
tigators and their organisations and of other collabora-
tors and participants.
Ethics and research governance
The CORONIS Trial was approved by OXTREC (Oxford
Tropical Research Ethics Committee (013–06a), and by
the relevant research ethics committees in each of the
participating countries and centres. Approval for the
follow-up study will require similar approvals. The trial
is being conducted according to the MRC Guidelines for
Good Clinical Practice. The follow-up study will have
similar governance structures.
The CORONIS Trial Steering Committee have agreed
to continue as the CORONIS Follow-up Study Steering
Committee (SSC). This includes the following independ-
ent members:
Professor Jim Neilson (Obstetrician)
Miss Felicity Ashworth (Obstetrician)
Professor Simon Cousens (Statistician)
Dr Debbie Chippington Derrick (Consumer representative)
Professor Manorama Purwar (Obstetrician)
Dr Catriona Waddington (Consumer representative)
The CORONIS Follow-up Study starts after recruit-
ment to the trial finishes. Emerging results from the
follow-up study cannot therefore influence recruitment
to the trial, however, it is possible that early results from
the follow-up study demonstrate clear evidence of bene-
fit or harm for one or more interventions or for particu-
lar groups of women within the trial, which would beexpected to influence clinical practice and therefore jus-
tify early publication of interim findings. Therefore, dur-
ing the follow-up period, unblinded interim analyses will
be supplied, in strict confidence, to the SSC at their an-
nual meeting, together with any other analyses the SSC
may request. Prior to their first meeting, the SSC will
define criteria for premature release of data similar, in
principle, to the stopping guidelines used by Data Moni-
toring Committees.
Collaborators and all others associated with the study
may write through the International Co-ordinating
Centre (ICC) to the SSC to draw attention to any con-
cern they may have arising from follow-up interviews
with women, or about any other matters that may be
relevant.
International Co-ordinating Centre
The NPEU Clinical Trials Unit at the University of Ox-
ford will be the ICC and will be responsible for the day-
to-day running of the on-going trial and the follow-up
study.
Regional Trial Offices and participating centres
Each country has a trial office with responsibility to the
Regional Co-ordinator. There are two trial offices in
India, one in Delhi and one in Vellore. The trial office is
responsible for one or more participating hospitals in
their country or region.
Argentina




Hospital Interzonal General de Agudoa Dr. José Penna
Bahia Blanca
Argentina
Hospital Dr. José María Cullen
Sante Fe
Argentina
Hospital J. B. Iturraspe
Sante Fe
Argentina




Hospital Pontifica Universidad Católica de Chile
Santiago
Chile
Sótero Del Río Hospital
Santiago
Chile
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Komfo Anokye Teaching Hospital
Kumasi
Ghana
India - (north) Delhi




Maulana Azad Medical College & Lok Nayak Hospital
New Delhi
India









India - (south) Vellore




























ICC: International Co-ordinating Centre; NPEU: National Perinatal
Epidemiology Unit; CTU: Clinical Trials Unit; RTO: Regional Trial Office;
SAP: Statistical Analysis Plan; SSC: Study Steering Committee; TSC: Trial
Steering Committee.
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